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Abstract
Embryonic stem cells are defined by their pluripotent status, which allows them to
differentiate  toward all  cell  types  of  an adult  organism.  This  pluripotency can be
characterized through many parameters, ranging from morphological traits, over certain
enzymatic activities, to the expression of specific pluripotency factors, taken into account
that these parameters may vary depending on the pluripotent stem cell type. As such,
considerable differences are seen between human and mouse embryonic stem cell (ESC),
or more generally stated, between primed and naïve pluripotent stem cells. This chapter
offers an overview of the markers involved and the molecular biology techniques to
monitor them during both ESC culture maintenance or differentiation experiments.
Keywords: Embryonic stem cells, Pluripotency, Pluripotency assessment, Noninva‐
sive monitoring, RT-qPCR
1. Introduction
The hallmarks of embryonic stem cells (ESC) are their potential for self-renewal and their
pluripotent status. The latter ensures that they can differentiate toward the three germ layers
(endoderm, mesoderm, and ectoderm) and primordial germ cells, and eventually to all different
cell types of an adult organism.
The first mouse ESC (mESC) were derived in 1981, independently by two different research
groups [1, 2]. The first human ESC (hESC) in culture followed almost 20 years later [3]. Up to
date, also for the derivatization of ESC from other species considerable research efforts have
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been made [4]. As ESC are being derived from the inner cell mass of a blastocyst, they provide
a good model to study fundamental processes in early development and cellular differentia‐
tion.
Equally important is that they also served as a template for the generation of induced pluri‐
potent stem cells (iPSC) and contribute to a better (clinical) application of these cells in the
future. As such, also in the field of induced pluripotency, tremendous progress has been made
over the last decade. In 2006 and 2007, respectively, the research group led by Shinya Yama‐
naka developed a reprogramming cocktail for the establishment of mouse and human iPSC [5,
6].
Nevertheless, as the comparison of the different ESC and iPSC types teaches us, pluripotency
comes in different intensities, instead of a single definition as was firstly assumed [7]. mESC
are considered as ‘true’ pluripotent ESC and find themselves in a ground pluripotent state, as
does the early preimplantation epiblast. hESC on the other hand, are primed pluripotent cells
and resemble more to mouse epiblast stem cells (mEpiSC), which are derived from a postim‐
plantation epiblast, in terms of culture requirements and molecular profile among other
factors.
This chapter will give an overview on those different types of pluripotency and their according
characteristics, and will then further elaborate on how these features can be monitored in order
to keep track of the pluripotent status of ESC in culture.
2. Primed versus naïve pluripotency
hESC are considered to be primed, in that they are already predestined for one lineage or
another, despite their remaining broad differentiation potential. In contrast, mESC are termed
as ‘naïve’ pluripotent cells, while mEpiSC form the primed counterpart. It is clear that these
different types possess different characteristics, which can be monitored via a range of different
features and techniques, as is outlined below in more detail.
2.1. Pluripotent ESC morphology
A first distinctive feature is the difference in morphology. Naïve mESC form dome-shaped
colonies, as do miPSC. However, primed hESC show a more flat morphology, with round
individual cells having a high nucleus-to-cytoplasm ratio, as such resembling mEpiSC. These
distinct appearances thus illustrate the different developmental states of the different cell
types. The conversion of hiPSC to their naïve form changes the morphology from flat to domed
[8]. It is remarkable how well these iPSCs resemble ESC in terms of morphology, even on an
ultrastructural level [9, 10]. The latter reference describes the comparison of mESC, mouse
embryonic fibroblasts (MEF), and iPSC derived thereof: after reprogramming, the accompa‐
nying morphological changes that the iPSC undergo make them virtually indistinguishable
from ESC. Nevertheless, within the population of morphologically similar miPSC colonies,
there still appears to be considerable variation in terms of molecular pluripotency, in contrast
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to hiPSC, which show a much higher homogeneity among the colonies that are selected on
analogous morphology [11]. Moreover, true hiPSC colonies have a typical hESC morphology
that is very distinct from non-hiPSC colonies, hence morphology can very well serve as a
criterion for identifying the real hiPSC colonies.
It is important to monitor the colonies' morphology in culture, as this will quickly visualize
potential spontaneous differentiation. E.g. for hESC, if two or more colonies come into contact
with one another, differentiation sets in at the contact area, and cells will start to pile up and
acquire a more lengthened shape. Also in the center of a colony, cells might start to accumulate
in multiple layers. As hESCs typically form flat colonies, timely passaging (at least on weekly
basis, dependent on the culture system) is crucial to prevent overgrowing colonies and
consequential spontaneous differentiation [12].
2.2. Pluripotency on a molecular level
2.2.1. Signalling pathways
The pluripotent state is regulated and maintained via several signaling pathways. As such,
four major pathways involved in pluripotency can be distinguished for hESC: (1) the trans‐
forming growth factor β (TGFβ)-Activin-Nodal pathway, (2) the phosphatidylinositol 3-kinase
(PI3K) pathway, (3) the Ras-Raf-mitogen activated protein kinase (MEK)-extracellular signal-
regulated kinase (ERK) (or MAPK/ERK) pathway, and (4) Wnt signaling [13–16].
TGFβ activates the TGFβ-Activin-Nodal pathway through the signal transducer SMAD2/3.
The latter forms a complex with Smad4 and then translocates to the nucleus to trigger the
expression of NODAL among other factors, which in turn stimulates self-renewal and inhibits
differentiation. Also, the addition of activin A to hESC culture enables the activation of this
pathway [14].
Addition of fibroblast growth factor (FGF; basic FGF; bFGF) on the other hand activates the
PI3K pathway and the Ras-Raf-MEK-ERK pathway. In short, for the PI3K pathway, phospha‐
tidylinositol 4,5-bisphosphate becomes phosphorylated by means of PI3K during activation.
The resulting phosphatidylinositol 3,4,5-triphosphate subsequently binds with Akt (also
known as protein kinase B). Activation of this pathway results in increased concentrations of
Oct3/4, Nanog and Sox2 and thus in the maintenance of pluripotency [16, 17]. Additionally,
activation of the Ras-Raf-MEK-ERK pathway leads to the activation of Ras (a GTPase), which
in turn binds with Raf. This kinase phosphorylates another kinase, MEK, which then phos‐
phorylates ERK (or MAPK). The latter translocates to the nucleus, leading to the phosphory‐
lation of c-Myc, c-Jun, and c-Fos, factors involved in stem cell renewal [18, 19].
The Wnt signaling pathway can be activated by several Wnt ligands and is stimulated in
culture e.g. by by 6-brominedirubin-3′-oxime. This agent inhibits glycogensynthase kinase-3
β which normally promotes the degradation of β-catenin in a complex with axin and adenom‐
atous polyposis coli protein, by making it a target for the proteasome [19, 20]. As a consequence
of this inhibition, β-catenin accumulates in the cytoplasm and a portion of this pool translocates
to the cell nucleus and interacts with genes important for keeping hESC undifferentiated [15].
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Importantly, reasonable differences exist between mESC and hESC in terms of signaling
pathways. In hESC, endogenous BMP signals (interacting with the TGFβ-Activin-Nodal
pathway) need to be suppressed [21], while on the contrary this pathway in mESC helps in
maintaining the pluripotent state and BMP-4 can be added to their culture medium. Analo‐
gously, leukemia inhibitory factor (LIF) is added to mESC media, which promotes self-renewal
by influencing Jak/Stat3 signaling, one of the downstream FGF/ERK pathways [13, 21]. hESC
on the other hand, are not dependent on LIF supplementation.
2.2.2. Transcription factors
As was already pointed out in the previous paragraph, the transcription factors Oct3/4, Nanog,
and Sox2 are part of the core pluripotency network. Oct3/4 (Octamer4 or Oct4, encoded by
POU5F1) has been termed the gatekeeper at the start of mammalian development. This
member of the Pit-Oct-Unc (POU) transcription factor family can activate its target genes'
expression through binding on an octameric sequence motif (consensus sequence AGT‐
CAAAT) [22]. Although not being totally exclusive for ESC, it is nevertheless considered as
one of the most important features to define a pluripotent cell state. In early embryos, loss of
POU5F1 expression causes the cells that were predisposed to form the ICM, to differentiate
toward trophectoderm cells. Also, in ESC, lowering Oct3/4 levels to ≤50% or an increased
expression above 150% leads to differentiation to trophectoderm or primitive endoderm cells,
respectively [13]. Oct3/4 also appears to support the maintenance of mammalian germ cells,
as apoptosis is induced when its expression is abrogated. Sox2 (SOX2) is a member of the SRY-
related high-mobility group box-containing family and cooperatively functions with Oct3/4.
However, its role goes further than just being a synergistic factor. Sox2-null embryos fail to
give rise to ESC, but differentiate primarily to trophectoderm instead. Deletion of SOX2 in
hESC and mESC leads to differentiation, confirming Sox2 to be essential in itself to maintain
the pluripotent state [23]. Nanog (NANOG) is another crucial pluripotency- and self-renewal-
maintaining factor in both mESC and hESC. It was for instance shown that deletion of NANOG
resulted in loss of pluripotency and induced differentiation, both in mouse ICM and ESC [24].
Its ability to maintain pluripotency is found to be independent of LIF supplementation to the
cell culture. One of the possible mechanisms for self-renewal maintenance may be that Nanog
represses the transcription of differentiation-promoting genes such as GATA4 and GATA6 [13,
24, 25].
Oct3/4, Nanog and Sox2 are involved in an intensive autoregulatory loop, as was for instance
shown by the fact that knockdown of Sox2 led to a reduced expression of Oct3/4 and Nanog
[23]. Additionally, they share a whole number of target genes, both in an activating or
inhibitory manner. They stimulate genes involved in chromatin remodeling, histone post‐
translational modifications, TGFβ signaling, etc., and other ESC transcription factors, among
which also themselves. They are able to inhibit the expression of many genes promoting
ectoderm, mesoderm, or endoderm differentiation [26]. It was found recently that among other
factors, the hypoxia inducible factor 2-α (HIF 2-α) is an upstream regulator of these key
transcription factors, as it binds directly to predicted hypoxic response elements in the
proximal promotor of POU5F1, NANOG, and SOX2 [27].
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This list of core pluripotency factors can be completed with Klf4, a member of the Krupple-
like Factor family. Together with other members of its family, it helps in maintaining ESC self-
renewal and regulating the expression of several other genes such as NANOG. It is also one of
the components included for iPSC generation starting from human or mouse cells, in combi‐
nation with POU5F1, SOX2, and c-MYC. Alternatively, a combination of POU5F1, NANOG,
LIN28, and SOX2 is applied for reprogramming.
Besides the aforementioned factors, there is a whole series of other transcription factors that
are involved in pluripotency regulation and maintenance. For instance, for hESC, the expres‐
sion of REX1, FOXD3, GDF3, GABRB3, EBAF, POXDL, NODAL, ZFP42, LIN28, TCF3,
EOMES, and SFPR2 is highly correlated to the expression of NANOG or are potential Nanog
targets, as was elaborately described in [28]. Of note, there was also a number of genes found
to be highly negatively correlated with NANOG expression, including CDX2 and CGB
(associated with trophectoderm differentiation), GATA6 and AFP (extraembryonic endo‐
derm), and PAX6 and NEUROD1 (neural lineage), once more confirming the role of Nanog in
pluripotency regulation [28]. In mESC, the sustaining of the pluripotent status relies both on
similar (e.g. NANOG, POU5F1, SOX2, REX1, and FOXD3) and different (e.g. PECAM1 and
STELLA) factors.
Yeo et al. [29] proposed the monitoring of DNA methylation patterns as a possible means to
study the extent of hESC differentiation. DNA methylation is mostly associated with tran‐
scriptional repression, whether established via chromatin remodeling complexes or by direct
blocking of transcription factor binding, and is as such involved in cellular programming
events [30, 31]. During the hESC differentiation process toward embryoid bodies, the promotor
regions of POU5F1 and NANOG undergo substantial methylation, in contrast to those of SOX2,
REX1, and FOXD3 [29].
2.2.3. Pluripotency on RNA level
Besides the well-described transcription factors and cell surface markers, also long noncoding
RNAs (lncRNAs) take up their role in pluripotency maintenance [32]. lncRNA molecules are
transcripts from RNA polymerase II, that are over 200 nucleotides in size and that do not serve
as a template for protein production. Instead, they prove to be involved in processes such as
mRNA stability and translation modulation, and related epigenetic regulatory processes [33].
Both for mESC and hESC a characteristic set of lncRNAs has yet been identified, of which some
are under the direct control of the core pluripotency transcription factor network [32]. The
authors of the latter publication provide an elaborate overview of the different lncRNAs
involved in the maintenance of ESC self-renewal and the preventing of differentiation. The
interaction of lncRNAs with histone modifiers and other chromatin-associated proteins has
been described in ESC, and they might serve as a scaffold to connect different chromatin
modifying complexes.




Also the expression of certain lamin proteins may serve as a marker for ESC differentiation
[34]. Nuclear lamins are intermediate filament proteins within the nuclear lamina, that not
only fulfill their role in the structural organization and support to the nuclear envelope but
also participate in processes such as DNA replication and transcription. This family of proteins
can be divided into 2 subgroups: lamins of the B-type (B1, B2, and B3) and of the A-type (A,
AΔ10, C, and C2). Lamins B1 and B2 are expressed in both embryonic and adult cells, while
A-type lamins are primarily found in differentiated cells, as was described for mouse and
human cells. Nevertheless, when neuronal differentiation was induced in hESC, the expression
of lamins A/C increased, as was also the case when differentiating toward cardiomyocytes.
The authors hypothesize that the mechanism of action can be two-fold. A/C lamins might keep
the differentiated state by directly influencing the nuclear structure and making it more rigid
and thus less prone to chromatin remodeling, a process occurring during cellular differentia‐
tion. Alternatively or in complement, these lamins might also indirectly lock a specific gene
expression pattern, by affecting the expression of other genes, as their interactions with several
transcription factors have yet been described. In those hESC differentiation experiments, the
authors could not point out a direct link with the expression of Oct3/4, as the expression of
both markers overlapped in most cells, both in a high or low expression level or as one marker
being more abundant than the other. The fact that A-type lamins are already present before
total Oct3/4 decrease, makes these lamins a good marker for the indication of early differen‐
tiation. Of note, there was no overlapping expression found with TRA-1-60, TRA-1-81 or
SSEA-4. For mESC, it has been described that they do show very low but yet detectable levels
of Lamin A/C even when pluripotent, albeit in a much lower pattern than for differentiated
cells [35].
2.2.5. Cell surface markers
Surface antigens are a valuable tool not only for the monitoring of the (non-)differentiation of
stem cells but also for the isolation of a subset of cells. The function of most of these markers
is not yet fully elucidated, a search that is further hampered because of their different
expression patterns in different pluripotent cell types. Some antigens are associated with
carbohydrate epitopes, linked with glycolipids (e.g. SSEA-3) or with glycoproteins (e.g.
TRA-1-60), and it has been hypothesized that the core structures of these antigens are essential
for the cellular function. For instance, the Lewis-X carbohydrate structure recognized as
SSEA-1 may be important for compaction at the morula stage during mouse embryonic
development [36].
One of the most well-known types of ESC surface markers is the class of stage-specific
embryonic antigens (SSEA), which are of the glycosphingolipid-type. Undifferentiated hESC
express SSEA-3 and -4 (globoseries structure), while SSEA-1 (lactoseries structure) is only
expressed in low levels [36, 37]. Upon hESC differentiation, the expression of these markers is
quickly downregulated, with SSEA-3 disappearing faster than SSEA-4. On top of that, there is
a significant increase in SSEA-1 [38]. Contrastingly, the reversed pattern is seen in pluripotent
mESC [36, 39]. Also another SSEA-molecule, namely, SSEA-5, has been identified on the
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surface of hESC, which undergoes an even larger reduction upon differentiation than SSEA-3
or -4 [40]. Their expression depends on the combined actions of the different enzymes that are
involved in their synthesis. Also the modified expression profile upon differentiation is
primarily directed by an altered expression of the key glycosyltransferases (GT), with an
upregulation of ganglio-related GT and simultaneous downregulation of globo- and lacto-
series-related GT [41]. Of note, this list of glycosphingolipids is far from complete; hESC
additionally express several other, less well-known markers of this type, of which the expres‐
sion rapidly diminishes upon differentiation [38]. Although the SSEA have been challenged
not to be essential for pluripotency maintenance [42], but to fulfill a role in cellular differen‐
tiation instead, their presence is nevertheless still considered as one of the criteria that must
be fulfilled to categorize a cell as pluripotent.
TRA-1-60 and TRA-1-81 are surface carbohydrate antigens present on hESC [36, 37], but not
in mESC [36, 39]. Retinoic acid-induced hESC differentiation significantly downregulates their
expression [37]. They have been shown to interact with keratan sulphated proteoglycans,
although the exact structural determinants of their epitopes remain unknown [43]. Their
expression is related to that of podocalyxin, a transmembrane glycoprotein, which has yet been
found to be highly expressed in both ESC and iPSC, and might serve as a carrier for the TRA-
antigens [44]. Cell surface glycans on ESC might play a role in the modulation of multiple
signaling pathways [43].
Besides the more frequently indicated SSEA- and TRA-markers, also several other categories
of surface molecules have been described. Cluster of differentiation (CD) antigens can be
subdivided into several classes such as integrins, adhesion molecules, glycoproteins, and
receptors [36]. Some of them such as CD9, CD24, and CD133 are associated with mESC and
hESC [36]. Of note, CD133 is also expressed in other cell lines like embryonic carcinoma cells
and hematopoietic stem cells [36]. Integrins are important for keeping ESC undifferentiated.
These cell surface receptors can bind several extracellular matrix proteins such as fibronectin,
vitronectin, collagen, and laminin and provide in this way the cell-matrix interaction [36, 45].
Next to the pluripotency cell surface markers, a range of markers for differentiation has been
described. Depending on the differentiation protocol applied, specific markers can be inves‐
tigated. On top of the markers already mentioned under paragraph 2.2.2, SSEA-1 and Gata4
for example indicate hESC endoderm differentiation, and the possibilities are still expanding.
For instance, Holtzinger et al. recently described new markers for hepatocyte differentiation
from hESC and hiPSC [46].
2.2.6. Alkaline phosphatase
Tissue-nonspecific alkaline phosphatase (TNAP or AP) is a membrane-bound glycosylated
enzyme which is highly expressed in pluripotent ESC [3, 47], and is rapidly upregulated upon
the reprogramming of somatic cells into iPSC. Of note, the expression of AP is absent in
mEpiSC [48]. AP expression significantly decreases during differentiation, making it a suitable
marker for pluripotency assessment. One way to monitor AP in hESC is detection with
TRA-2-29 and TRA-2-54 antibodies [36, 49]. Its specific function is not totally elucidated, but
its importance for ESC is ascribed to its role in the metabolism of vitamin B6 and thus also of
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the neurotransmitter γ-aminobutyric acid (GABA), a process that is considered to be impera‐
tive for ESC proliferation and self-renewal regulation. Additionally, it is very likely that
because of the high proliferative rate of ESC, their need for substrate dephosphorylation is
considerably higher than in somatic cells [48]. The activity of AP is highly correlated with its
expression, which is mainly driven by the actual microenvironment of the cell, instead of via
specific signaling pathways. MAPK p38 might play a role in AP’s expression regulation, as
deletion of p38 in ESC led to a decreased AP expression and activity, but the precise mechanism
remains unknown.
2.3. Other pluripotency features
A high level of telomerase activity is also one of the typical ESC characteristics [3]. Telomerase
is involved in maintaining telomere length and is able to add telomere repeats to chromosome
ends. As such it plays an important role in sustaining the replicative time-span and self-
renewal of ESC. Somatic cells do not display any telomerase activity, leading to shortened
telomeres over time and entering senescence after a certain number of cell divisions. Even in
adult stem cells only low levels of telomerase activity can be found, in contrast to ESC [50].
Pluripotent hESC also display an abbreviated cell cycle of about 16 h, in comparison to
differentiated cells, due to a shortened G1 phase [51, 52]. Similarly, also mESC proliferate
quickly and have a lengthening cell cycle upon differentiation. Because of their high prolifer‐
ative pace, both mESC and hESC cultures need to be passaged very frequently, although the
passaging technique is different between those two culture types: naïve cells are way more
tolerant for single cell passaging than primed cells and thus allow better for bulk culture.
Besides confirming the presence or absence of certain characteristic traits, the most stringent
way to show pluripotent potential is chimera formation. However, as hereby ESC are injected
into a developing embryo, this is for obvious ethical reasons not possible for hESC. Addition‐
ally, pluripotency can be investigated through spontaneous ESC differentiation in vivo
(teratoma formation) and/or in vitro (embryoid body formation). Alternatively, also the
directed differentiation under stimulation by specific growth factors, small molecules, gene
manipulation, etc. toward specific cell types can be assessed.
3. Pluripotency monitoring
3.1. Overview
The pluripotent state and cellular differentiation can be followed by means of multiple
techniques, depending on the cell lines used, the experimental set-up, etc. As a start, micro‐
scopy is a very important asset in this monitoring process. Cell cultures' performance, colony,
and individual cell morphology (whether or not during differentiation) can be checked by
means of light microscopy. With the implementation of additional stainings with fluorescently
labelled antibodies and nuclear stains (e.g. DAPI), a whole range of other parameters like
nuclear morphology, the presence of core transcription factors, cell surface molecules, and
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intracellular markers can be assessed with fluorescence microscopy. Often specific kits are
available for a defined marker panel for pluripotency assessment of both ESC and iPSC lines,
such as the Fluorescent hESC/hiPSC Characterization Kit provided by Millipore [53]. A
noninvasive method for daily check-up of hESC cultures with microscopy is further described
in Section 3.2. As an alternative, flow cytometry analysis after immunostaining can be applied
for monitoring those markers. This technique is also applied for the analysis of cell proliferation
rates and the distribution of a cell population across the different cell cycle phases.
A relatively quick way to obtain gene expression data of the described pluripotency factors,
differentiation markers, lncRNAs, lamin proteins, etc., is the application of reverse transcrip‐
tion-quantitative PCR (RT-qPCR); one such protocol for relative quantification is described
under paragraph 3.3. Larger transcriptomics experiments can be set up by means of microarray
analysis and next-generation sequencing. To detect these markers' expression on a protein
level, also multiple techniques are available such mass spectrometry, or 1D or 2D gel electro‐
phoresis combined with Western blotting.
Enzymatic activities of e.g. alkaline phosphatase and telomerase can be determined with
specific kits available for cells of both human and murine origin. Telomerase activity is most
often checked by means of a TRAP assay, or telomeric repeat amplification protocol, in which
the telomerase activity is (semi-)quantified with qPCR after an initial enzymatic incubation
step. Also ELISA-based methods have been described, whether or not in combination with
TRAP (elaborately reviewed in [54]). AP activity detection is often based on colorimetric
assays, e.g. performed on the supernatant of cell cultures. Even live stains are available, that
allow noninvasive monitoring with microscopy. Hereby a non-fluorescent substrate is added
to the cell culture, that becomes fluorescent after dephosphorylation by AP. Such a cell-
permeable and non-toxic fluorescent substrate does not accumulate in the cells but diffuses
out of the cells after 2 h [49], and thus does not yield any problems for following analyses.
3.2. Noninvasive monitoring
3.2.1. Background
As described above, immunostaining and RT-qPCR are most often used methods for pluri‐
potency and differentiation screening. Nevertheless, for those methods, ESC need to be
harvested, which thus makes it impossible to monitor the same colony over and over again on
a daily basis, as new samples have to be collected for each analysis. We present a method
enabling pluripotency monitoring of the same specific colonies during a time-lapse experiment
by using a reporter ESC line, as was published by Scheerlinck et al. [55].
3.2.2. Experimental aspects and workflow
A commercially available Oct3/4-eGFP Knock-In hESC line was used, in which the transcrip‐
tion of enhanced green fluorescent protein (eGFP) is coupled to the transcription of POU5F1
[56]. After eGFP translation, a fluorescent signal (ex. 489 nm, em. 511 nm) is detected, which
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can be measured using a flow cytometer (FC) or fluorescence microscope (FM) [57]. When
using the latter, not only the pluripotency can be measured but also the morphology can be
examined. FC can then be used to validate the FM results obtained and was thus used as a
reference. However, FC was only used at the end of the experiments, because it requires cell
harvesting and fresh samples, making the monitoring of the same specific colonies on a daily
basis impossible.
This method can be applied both for feeder and feeder-free hESC culture conditions. Hence,
a comparison was made between hESC cultured on MEF with regular DMEM/F-12 medium
(with 4 ng/mL bFGF) on one hand and hESC on vitronectin-coated plates in combination with
Essential 8 medium on the other. Both culture conditions were kept undifferentiated as for a
regular ESC culture. Simultaneously, a differentiation experiment was set up, where differ‐
entiation was induced in case of MEF culture by omitting bFGF from the culture medium
(spontaneous differentiation), whether or not combined with the addition of 2 μM retinoic acid
(forced ectoderm differentiation). For feeder-free culture, only the latter condition with retinoic
acid was applied. As such, there were in total three MEF conditions and two feeder-free
conditions analyzed. The resolving power of the FM to compare differentiation status differ‐
ences was determined by the comparison of those five conditions, of which only the ones
containing bFGF are assumed to keep the hESC pluripotent. The resolving power of FC was
determined by a complete 15-day differentiation of the Oct3/4 reporter cell line: the fluorescent
signal quickly decreased during the first week and completely disappeared after 15 days in
culture, falling back to the same level as UGENT2-cells, a non-reporter hESC line.
Importantly, possible auto-fluorescence of both the medium and the cells themselves needs to
be investigated. Several amino acids (tryptophan, tyrosine, and phenylalanine) and vitamins
(riboflavin) among other factors, all present in DMEM/F-12, are known to cause auto-fluores‐
cence [58–60]. Subsequently, also non-reporter hESC (in our case the UGENT2 cell line) and
MEF in case of feeder cultures need to be analyzed. When using FM, the signal-to-noise (S/N)
ratio for each hESC colony can be determined by dividing the densitrometric mean of the
colony (signal) by that one of its background (noise). For FC analysis of feeder cultures, it was
not possible to distinguish the MEF population from the hESC in terms of FS/SS. Ideally, these
MEF should be isolated by means of fluorescence-activated cell sorting after immunostaining
for a specific marker such as vimentin or CD90 [61]. However, as FC is only used at the end of
the experiment only a small contribution of the MEF (<10%) to the fluorescence histogram is
expected, as the relative portion of the inactivated MEF gradually reduces over time compared
to the growing hESC colonies.
3.2.3. Outcome
As stated above, the UGENT2 cell line and MEF were included in the analysis to determine
the background auto-fluorescence. For FM, the MEF did not yield a detectable auto-fluores‐
cence signal and did thus not impact the S/N ratio in comparison to feeder-free cultured hESC,
although FC analysis revealed a low but present MEF auto-fluorescence intensity (Figure 1A).
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Figure 1. Noninvasive monitoring of hESC colonies. (A) Auto-fluorescence assessment by FC. (B) Results obtained by
FM, expressed as S/N ratios. The differentiating conditions clearly show a decreased S/N ratio in comparison to the
cells kept pluripotent. (C) FC results obtained at the end of the differentiation experiment, confirming the FM results.
(D) Microscopic fluorescent images of a hESC colony in MEF culture conditions, under spontaneous (left) and retinoic
acid-induced (right) differentiation.
For FM assessment, colony fluorescence was measured daily for 5 or 6 colonies per condition,
during 6 days. The experiment was performed in triplicate and the obtained results are
expressed as S/N ratios. As expected, addition of retinoic acid (directed differentiation) caused
a significant decrease in S/N ratio over time both in feeder and feeder-free culture conditions,
indicating a lowering expression of Oct3/4 in the course of the differentiation process. Also
only omitting bFGF from the culture medium definitely leads to differentiation, as was
confirmed by the decreasing S/N ratios, albeit in a slower rate than when also retinoic acid is
added. No significant S/N ratio differences were found between feeder and feeder-free hESC
cultures for both the non-differentiating and the differentiating conditions, confirming the low
impact of MEF auto-fluorescence on FM measurements. Of note, for both undifferentiated
culture conditions, an increase in fluorescence was seen toward the end of the experiment,
which might be explained by an increase in eGFP/cell or more plausibly by the formation of
multilayers (3D growth) resulting in an accumulation of fluorescent signal (Figure 1B).
The FM data were compared to the results of a FC hESC analysis (Figure 1C). As mentioned
above, because of the destructive nature of this technique, this measurement is only performed
at the end of the experiment. Both feeder-free and MEF grown hESC in the presence of bFGF
retained their undifferentiated status. Of note, a small portion of cells in the latter population
had a lower eGFP expression, most probably MEF as mentioned earlier (auto-fluorescence
between 100 and 101, asterisk in Figure 1C). The finding that the eGFP signal/cell remained
constant in the undifferentiated conditions indeed confirms that the daily increase in fluores‐
cence as observed by FM is rather due to a multilayer effect resulting in an accumulated
fluorescent signal. In the MEF condition without bFGF, most of the cells were still undiffer‐
entiated after 6-day culture (signal >101) but in comparison, in the condition with bFGF a
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significantly higher number of cells with a 100 and 101 eGFP expression were observed. These
results are in line with the FM measurements, in which it was shown that there is indeed a mix
of differentiated (low fluorescence; S/N ratio = 2.26) and undifferentiated hESC (high fluores‐
cence, S/N ratio = 13.75) on day 5 of spontaneous differentiation (Figure 1D left). The conditions
with retinoic acid showed a clear drop in fluorescence toward the end of the experiment, as
also confirmed by the FM results. Remarkably, FM images of retinoic acid differentiated hESC
colonies on MEF revealed the existence of demarcated zones with highly accumulated
fluorescence (S/N ratio = ca. 24) (Figure 1D right). This small population of high fluorescent
‘islands’ could not be discriminated using FC as these individual highly fluorescent cells were
somewhat hidden in the tail of the fluorescence histogram.
In conclusion, it is important to bear in mind that for FM assessment, an increasing fluorescence
intensity of a hESC colony does not correlate with an increased eGFP signal per cell, but with
hESC growing in multiple layers. As such, only a decrease in signal can be directly interpreted
as ongoing differentiation. A flat signal can be considered as an hESC culture with both
pluripotent and differentiating cells [55].
Despite its usefulness, this method still has some limitations. One issue is the auto-fluorescence
of the medium, necessitating the use of a different medium than that used for regular culture.
In this experiment, hESC colonies were analyzed by using no medium at all, although this
evokes stress to the cells. ThermoFisher has recently developed an auto-fluorescence-free
medium called FluoroBrite DMEM, which can be used as basal medium for analysis during
fluorescence [58]. It should nevertheless be further investigated whether this medium can also
be used for hESC. Secondly, ideally the analysis should be done in the same conditions as
during culture, meaning that a cell imaging system with regulated O2 and CO2 supply would
be more appropriate. Different companies such as Zeiss could offer a solution in this regard.
Nevertheless, even if a microscope as described in the experiments above is used, the fact that
the cells are monitored in culture enables an immediate follow-up of their behavior.
3.2.4. Applications
The application of this method is definitely not restricted to an Oct3/4-eGFP ESC line but can
be used for any reporter cell line, as long as potential auto-fluorescence is overcome, e.g. by
the implementation of an auto-fluorescence-free cell culture medium. For instance, also
Nanog-eGFP reporter hESC lines are available [62], as is an hRex-GFP hESC line [63]. Addi‐
tionally, reporters for specific differentiation markers have been generated, with an increasing
GFP expression during the course of the differentiation process, e.g. [64, 65]. The production
of a Nanog-eGFP reporter to monitor fibroblast reprogramming has been published, too [66].
A reporter cell line including multiple markers clearly strengthens the use of the method
described above. For example, Maass et al. created a reporter mESC line harboring Cntn2-eGFP
and MHCα-mCherry, which will be upregulated during directed cardiac differentiation, as
such allowing to monitor the development of cardiac progenitors [67]. However, to our
knowledge, the development of a dual reporter ESC line combining two pluripotency markers
has not been published. Furthermore, most reporter ESC lines described express (e)GFP, thus
ruling out a possible combination with GFP-based alkaline phosphatase live stain [68].
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However, ActivMotiv provides a CDy1 Dye (ex. 544 nm/em. 577 nm) to detect pluripotent
stem cells live in culture, that can be combined with GFP expression [69, 70].
3.3. Quantitative PCR monitoring
3.3.1. Background
As mentioned above, one other efficient method to monitor the expression profile of multiple
target genes (e.g. the core pluripotency transcription factors) is RT-qPCR. This technique
allows to analyze samples in high throughput, at a relatively low cost. In this way, it can easily
be applied for e.g. pluripotency monitoring of (long term) ESC cultures, as was recently
elaborately described for hESC by Galán and Simón [71]. Besides culture monitoring, it can
also be applied for the comparison of pluripotent and differentiating ESC. Importantly, as goes
for all experimental work, also here an adequate set-up is of utmost importance. During RT-
qPCR data analysis, a suitable normalization factor should be taken into account, to correct for
potential technical variabilities that were included along the experimental process. To this end,
multiple strategies have been used. Normalization to the number of cells might not be accurate
and cell enumeration is particularly less easy when dealing with adherent cell cultures such
as ESC [72]. Moreover, this normalization strategy does not take into account the variability
that might have been included during sample preparation such as potentially insufficient
enzymatic reaction efficiencies. Alternatively, correcting toward RNA mass quantity has been
described, but also here the same issue applies, as potential technical variation from the
complementary DNA (cDNA) preparation from messenger RNA (mRNA) is not considered.
Ribosomal RNA (rRNA) makes up the major part of the total RNA pool and may be prone to
regulation, which will cause a variable ratio between rRNA and mRNA. Hence, normalization
for the total RNA content may not be representative for the amount of mRNA [72, 73]. The by
far mostly favored method for data normalization is correcting to one or preferentially multiple
reference or so-called housekeeping genes. This allows the researcher to correct for any
variation between samples that might have been implemented along the protocol. These
reference genes are expected to be expressed in a stable manner throughout all samples of a
given experimental set-up.
3.3.2. Experimental aspects and workflow
To determine which references need to be included, different algorithms are available such as
BestKeeper or Normfinder, but the most widely used is the geNorm algorithm, included in
the qBase software (Biogazelle) [74]. We applied the latter to find suitable reference genes to
be used for the comparison between pluripotent and differentiating hESC [75]. After putting
in all RT-qPCR data, the software calculates a so-called stability value (designated ‘M value’)
for each candidate, with a low M value indicating a higher gene expression stability throughout
all samples. Afterwards, all reference candidates are ranked according to that value and the
most adequate reference genes can be selected.
A differentiation experiment was set up, in which hESC samples from two different cell lines
(UGENT1 and UGENT2) were collected daily during 8 days after retinoic acid-induction, plus
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an extra sample on day 12 of differentiation (Experiment 1). This was repeated in two more
experiments, albeit in a different time window: in Experiment 2 samples were collected daily
during 6 days and in Experiment 3, cells were harvested every 4 h during day 3, 4, and 5 after
onset of differentiation. After RNA isolation, quality control and cDNA preparation, RT-qPCR
reactions were run in duplo, on an ABI Prism 7000 Sequence Detection System (Applied
Biosystems) and a LightCycler 480 (Roche). Twelve reference loci candidates were included,
mainly with SYBR Green detection (allowing melting curve analysis), except for GAPDH and
PPIA, for which specific probes were used. All data were imported in geNorm and assessed
for expression stability.
3.3.3. Outcome
According to the geNorm analysis performed for all three differentiation experiments, the most
stable reference loci among the 12 included candidates were B2M, RPL13A, and Alu repeats.
In contrast, the more classic reference genes such as GAPDH or ACTB did not perform so well
(all M values listed in Figure 2) [75]. These findings were corroborated by the results obtained
from the use of other algorithms for reference gene stability determination.
Figure 2. Reference genes selection and their application. A geNorm stability analysis was performed for 12 candi‐
date reference genes; the table shows the resulting ranking. B2M, RPL13A, and Alu repeats appeared to be the most
suitable references, performing significantly better than the more classic reference genes GAPDH, ACTB, and PPIA as
is illustrated in the graph (fold change in expression over time during differentiation).
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It is important to bear in mind that different experimental settings may require different
references; e.g. one differentiation-inducing agent will not have the same influence on gene
expression in general as another. Previously defined reference loci might thus not be blindly
extrapolated to new experimental conditions. The difference in reference gene performance is
illustrated by the comparison between to reference sets: B2M, RPL13A, and Alu repeats on one
hand and GAPDH, PPIA, and ACTB on the other. These sets were used to normalize the
expression of the pluripotency factors POU5F1 and NANOG, which are supposed to decrease
considerably after differentiation is induced. However, that decrease was significantly less
pronounced (p-value = 1.30e-05) when applying the more classic reference genes, once more
pointing out the importance of an adequate reference gene selection (graph Figure 2).
The fact that B2M, RPL13A, and Alu repeats are found to be the most stable genes is never‐
theless not too surprising. B2M is expressed in every nucleated cell as it is a component of the
major histocompatibility complex I. It is thus a very good candidate to apply as a normalization
scalar for RT-qPCR analysis (e.g. [76]). Also RPL13A, involved in the protein translation
process, has been widely used as a reference gene (e.g. [77]). The applicability of both genes
was confirmed by our own data analysis. The Alu repeats are of particular interest, as their
application provides a rather novel approach for data normalization [78]. These short inter‐
spersed elements are distributed genome-wide, which implies that a variation in the expres‐
sion of a single gene will not substantially influence the total expression profile of these
elements.
3.3.4. Applications
The setting described here specifies the monitoring of the pluripotency factors Oct3/4 and
Nanog, but obviously any other marker of which the expression should be monitored and
relatively quantified can be included. It is recommended to revaluate the reference genes'
stability if an experimental set-up would be modified, but once the most suitable references
have been established, any target gene can be implemented in this assay. As such, on top of
the pluripotency markers, also the expression of specific differentiation markers can be
monitored to follow development toward a certain cell lineage. This technique can as well be
used for the assessment of noncoding RNA genes.
4. Conclusion
This chapter gives an overview on a number of typical characteristics which can be monitored
to keep track of the pluripotent status of ESC cultures. Nevertheless, this list is far from
complete and it is most likely that in time new biomarkers will be found while known features
will be revaluated, as new culturing techniques are developed and the research field of induced
pluripotency and naïve pluripotency further expands. Also from a technological point of view,
novel methods will enhance these markers' detection and facilitate the discovery of new
molecules.
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